Global Monoclonal Antibody Diagnostic Reagents Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Monoclonal Antibody Diagnostic Reagents market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Monoclonal Antibody Diagnostic Reagents are reagents whose active ingredients are monoclonal antibodies to identify infectious agents, abnormal cells or elements of the body's response to disease.
In China, Monoclonal Antibody Diagnostic Reagents key players include Roche, Abbott, Beckman, BD, BioMerieux, etc. The top five players hold a share about 70%.
South Central China is the largest market, with a share about 30%, followed by East China and North China, having a total share about 40 percent.
In terms of product, Enzyme Linked Immunosorbent Assays is the largest segment, with a share about 40%. And in terms of application, the largest application is Virus Hepatitis Diagnosis, followed by Tumor Monitoring, Venereal Disease Diagnosis, etc.
LP Information, Inc. (LPI) ' newest research report, the “Monoclonal Antibody Diagnostic Reagents Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody Diagnostic Reagents sales in 2024, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Diagnostic Reagents sales for 2025 through 2031. With Monoclonal Antibody Diagnostic Reagents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Diagnostic Reagents industry.
This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Diagnostic Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibody Diagnostic Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monoclonal Antibody Diagnostic Reagents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Diagnostic Reagents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Diagnostic Reagents.
This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Diagnostic Reagents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Monoclonal Antibody Diagnostic Reagents market?
What factors are driving Monoclonal Antibody Diagnostic Reagents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monoclonal Antibody Diagnostic Reagents market opportunities vary by end market size?
How does Monoclonal Antibody Diagnostic Reagents break out by Type, by Application?
The global Monoclonal Antibody Diagnostic Reagents market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Monoclonal Antibody Diagnostic Reagents are reagents whose active ingredients are monoclonal antibodies to identify infectious agents, abnormal cells or elements of the body's response to disease.
In China, Monoclonal Antibody Diagnostic Reagents key players include Roche, Abbott, Beckman, BD, BioMerieux, etc. The top five players hold a share about 70%.
South Central China is the largest market, with a share about 30%, followed by East China and North China, having a total share about 40 percent.
In terms of product, Enzyme Linked Immunosorbent Assays is the largest segment, with a share about 40%. And in terms of application, the largest application is Virus Hepatitis Diagnosis, followed by Tumor Monitoring, Venereal Disease Diagnosis, etc.
LP Information, Inc. (LPI) ' newest research report, the “Monoclonal Antibody Diagnostic Reagents Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody Diagnostic Reagents sales in 2024, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Diagnostic Reagents sales for 2025 through 2031. With Monoclonal Antibody Diagnostic Reagents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Diagnostic Reagents industry.
This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Diagnostic Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibody Diagnostic Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monoclonal Antibody Diagnostic Reagents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Diagnostic Reagents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Diagnostic Reagents.
This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Diagnostic Reagents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Enzyme Linked Immunosorbent Assays
- Dot-immuogold Filtration Assay
- Double Antigen Sandwich Chemiluminescence Method
- Recombinant Immunoblot Assay
- Tumor Monitoring
- Virus Hepatitis Diagnosis
- Venereal Disease Diagnosis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- KHB
- Leadman
- BioSino
- Chemclin
- Wantai BioPharm
- Rongsheng
What is the 10-year outlook for the global Monoclonal Antibody Diagnostic Reagents market?
What factors are driving Monoclonal Antibody Diagnostic Reagents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monoclonal Antibody Diagnostic Reagents market opportunities vary by end market size?
How does Monoclonal Antibody Diagnostic Reagents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Monoclonal Antibody Diagnostic Reagents by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Monoclonal Antibody Diagnostic Reagents by Country/Region, 2020, 2024 & 2031
2.2 Monoclonal Antibody Diagnostic Reagents Segment by Type
2.2.1 Enzyme Linked Immunosorbent Assays
2.2.2 Dot-immuogold Filtration Assay
2.2.3 Double Antigen Sandwich Chemiluminescence Method
2.2.4 Recombinant Immunoblot Assay
2.3 Monoclonal Antibody Diagnostic Reagents Sales by Type
2.3.1 Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Type (2020-2025)
2.3.2 Global Monoclonal Antibody Diagnostic Reagents Revenue and Market Share by Type (2020-2025)
2.3.3 Global Monoclonal Antibody Diagnostic Reagents Sale Price by Type (2020-2025)
2.4 Monoclonal Antibody Diagnostic Reagents Segment by Application
2.4.1 Tumor Monitoring
2.4.2 Virus Hepatitis Diagnosis
2.4.3 Venereal Disease Diagnosis
2.4.4 Others
2.5 Monoclonal Antibody Diagnostic Reagents Sales by Application
2.5.1 Global Monoclonal Antibody Diagnostic Reagents Sale Market Share by Application (2020-2025)
2.5.2 Global Monoclonal Antibody Diagnostic Reagents Revenue and Market Share by Application (2020-2025)
2.5.3 Global Monoclonal Antibody Diagnostic Reagents Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Monoclonal Antibody Diagnostic Reagents Breakdown Data by Company
3.1.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales by Company (2020-2025)
3.1.2 Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Company (2020-2025)
3.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue by Company (2020-2025)
3.2.1 Global Monoclonal Antibody Diagnostic Reagents Revenue by Company (2020-2025)
3.2.2 Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Company (2020-2025)
3.3 Global Monoclonal Antibody Diagnostic Reagents Sale Price by Company
3.4 Key Manufacturers Monoclonal Antibody Diagnostic Reagents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Monoclonal Antibody Diagnostic Reagents Product Location Distribution
3.4.2 Players Monoclonal Antibody Diagnostic Reagents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MONOCLONAL ANTIBODY DIAGNOSTIC REAGENTS BY GEOGRAPHIC REGION
4.1 World Historic Monoclonal Antibody Diagnostic Reagents Market Size by Geographic Region (2020-2025)
4.1.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Monoclonal Antibody Diagnostic Reagents Market Size by Country/Region (2020-2025)
4.2.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales by Country/Region (2020-2025)
4.2.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue by Country/Region (2020-2025)
4.3 Americas Monoclonal Antibody Diagnostic Reagents Sales Growth
4.4 APAC Monoclonal Antibody Diagnostic Reagents Sales Growth
4.5 Europe Monoclonal Antibody Diagnostic Reagents Sales Growth
4.6 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Growth
5 AMERICAS
5.1 Americas Monoclonal Antibody Diagnostic Reagents Sales by Country
5.1.1 Americas Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025)
5.1.2 Americas Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025)
5.2 Americas Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
5.3 Americas Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody Diagnostic Reagents Sales by Region
6.1.1 APAC Monoclonal Antibody Diagnostic Reagents Sales by Region (2020-2025)
6.1.2 APAC Monoclonal Antibody Diagnostic Reagents Revenue by Region (2020-2025)
6.2 APAC Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
6.3 APAC Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Monoclonal Antibody Diagnostic Reagents by Country
7.1.1 Europe Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025)
7.1.2 Europe Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025)
7.2 Europe Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
7.3 Europe Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monoclonal Antibody Diagnostic Reagents by Country
8.1.1 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025)
8.1.2 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025)
8.2 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
8.3 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monoclonal Antibody Diagnostic Reagents
10.3 Manufacturing Process Analysis of Monoclonal Antibody Diagnostic Reagents
10.4 Industry Chain Structure of Monoclonal Antibody Diagnostic Reagents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Monoclonal Antibody Diagnostic Reagents Distributors
11.3 Monoclonal Antibody Diagnostic Reagents Customer
12 WORLD FORECAST REVIEW FOR MONOCLONAL ANTIBODY DIAGNOSTIC REAGENTS BY GEOGRAPHIC REGION
12.1 Global Monoclonal Antibody Diagnostic Reagents Market Size Forecast by Region
12.1.1 Global Monoclonal Antibody Diagnostic Reagents Forecast by Region (2026-2031)
12.1.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Monoclonal Antibody Diagnostic Reagents Forecast by Type (2026-2031)
12.7 Global Monoclonal Antibody Diagnostic Reagents Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 KHB
13.1.1 KHB Company Information
13.1.2 KHB Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.1.3 KHB Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 KHB Main Business Overview
13.1.5 KHB Latest Developments
13.2 Leadman
13.2.1 Leadman Company Information
13.2.2 Leadman Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.2.3 Leadman Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Leadman Main Business Overview
13.2.5 Leadman Latest Developments
13.3 BioSino
13.3.1 BioSino Company Information
13.3.2 BioSino Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.3.3 BioSino Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BioSino Main Business Overview
13.3.5 BioSino Latest Developments
13.4 Chemclin
13.4.1 Chemclin Company Information
13.4.2 Chemclin Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.4.3 Chemclin Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Chemclin Main Business Overview
13.4.5 Chemclin Latest Developments
13.5 Wantai BioPharm
13.5.1 Wantai BioPharm Company Information
13.5.2 Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.5.3 Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Wantai BioPharm Main Business Overview
13.5.5 Wantai BioPharm Latest Developments
13.6 Rongsheng
13.6.1 Rongsheng Company Information
13.6.2 Rongsheng Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.6.3 Rongsheng Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Rongsheng Main Business Overview
13.6.5 Rongsheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Monoclonal Antibody Diagnostic Reagents Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Monoclonal Antibody Diagnostic Reagents Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Enzyme Linked Immunosorbent Assays
Table 4. Major Players of Dot-immuogoldFiltration Assay
Table 5. Major Players of Double Antigen Sandwich Chemiluminescence Method
Table 6. Major Players of Recombinant Immunoblot Assay
Table 7. Global Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 8. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Table 9. Global Monoclonal Antibody Diagnostic Reagents Revenue byType (2020-2025) & ($ million)
Table 10. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share byType (2020-2025)
Table 11. Global Monoclonal Antibody Diagnostic Reagents Sale Price byType (2020-2025) & (USD/Dose)
Table 12. Global Monoclonal Antibody Diagnostic Reagents Sale by Application (2020-2025) & (K Dose)
Table 13. Global Monoclonal Antibody Diagnostic Reagents Sale Market Share by Application (2020-2025)
Table 14. Global Monoclonal Antibody Diagnostic Reagents Revenue by Application (2020-2025) & ($ million)
Table 15. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Application (2020-2025)
Table 16. Global Monoclonal Antibody Diagnostic Reagents Sale Price by Application (2020-2025) & (USD/Dose)
Table 17. Global Monoclonal Antibody Diagnostic Reagents Sales by Company (2020-2025) & (K Dose)
Table 18. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Company (2020-2025)
Table 19. Global Monoclonal Antibody Diagnostic Reagents Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Company (2020-2025)
Table 21. Global Monoclonal Antibody Diagnostic Reagents Sale Price by Company (2020-2025) & (USD/Dose)
Table 22. Key Manufacturers Monoclonal Antibody Diagnostic Reagents Producing Area Distribution and Sales Area
Table 23. Players Monoclonal Antibody Diagnostic Reagents Products Offered
Table 24. Monoclonal Antibody Diagnostic Reagents Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Monoclonal Antibody Diagnostic Reagents Sales by Geographic Region (2020-2025) & (K Dose)
Table 28. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share Geographic Region (2020-2025)
Table 29. Global Monoclonal Antibody Diagnostic Reagents Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Monoclonal Antibody Diagnostic Reagents Sales by Country/Region (2020-2025) & (K Dose)
Table 32. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country/Region (2020-2025)
Table 33. Global Monoclonal Antibody Diagnostic Reagents Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025) & (K Dose)
Table 36. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country (2020-2025)
Table 37. Americas Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 39. Americas Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 40. APAC Monoclonal Antibody Diagnostic Reagents Sales by Region (2020-2025) & (K Dose)
Table 41. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share by Region (2020-2025)
Table 42. APAC Monoclonal Antibody Diagnostic Reagents Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 44. APAC Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 45. Europe Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025) & (K Dose)
Table 46. Europe Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 48. Europe Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 49. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025) & (K Dose)
Table 50. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 52. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 53. Key Market Drivers & Growth Opportunities of Monoclonal Antibody Diagnostic Reagents
Table 54. Key Market Challenges & Risks of Monoclonal Antibody Diagnostic Reagents
Table 55. Key IndustryTrends of Monoclonal Antibody Diagnostic Reagents
Table 56. Monoclonal Antibody Diagnostic Reagents Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Monoclonal Antibody Diagnostic Reagents Distributors List
Table 59. Monoclonal Antibody Diagnostic Reagents Customer List
Table 60. Global Monoclonal Antibody Diagnostic Reagents SalesForecast by Region (2026-2031) & (K Dose)
Table 61. Global Monoclonal Antibody Diagnostic Reagents RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Monoclonal Antibody Diagnostic Reagents SalesForecast by Country (2026-2031) & (K Dose)
Table 63. Americas Monoclonal Antibody Diagnostic Reagents Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Monoclonal Antibody Diagnostic Reagents SalesForecast by Region (2026-2031) & (K Dose)
Table 65. APAC Monoclonal Antibody Diagnostic Reagents Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Monoclonal Antibody Diagnostic Reagents SalesForecast by Country (2026-2031) & (K Dose)
Table 67. Europe Monoclonal Antibody Diagnostic Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Monoclonal Antibody Diagnostic Reagents SalesForecast by Country (2026-2031) & (K Dose)
Table 69. Middle East & Africa Monoclonal Antibody Diagnostic Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Monoclonal Antibody Diagnostic Reagents SalesForecast byType (2026-2031) & (K Dose)
Table 71. Global Monoclonal Antibody Diagnostic Reagents RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Monoclonal Antibody Diagnostic Reagents SalesForecast by Application (2026-2031) & (K Dose)
Table 73. Global Monoclonal Antibody Diagnostic Reagents RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. KHB Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 75. KHB Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 76. KHB Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 77. KHB Main Business
Table 78. KHB Latest Developments
Table 79. Leadman Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 80. Leadman Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 81. Leadman Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 82. Leadman Main Business
Table 83. Leadman Latest Developments
Table 84. BioSino Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 85. BioSino Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 86. BioSino Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 87. BioSino Main Business
Table 88. BioSino Latest Developments
Table 89. Chemclin Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 90. Chemclin Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 91. Chemclin Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 92. Chemclin Main Business
Table 93. Chemclin Latest Developments
Table 94. Wantai BioPharm Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 95. Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 96. Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 97. Wantai BioPharm Main Business
Table 98. Wantai BioPharm Latest Developments
Table 99. Rongsheng Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 100. Rongsheng Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 101. Rongsheng Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 102. Rongsheng Main Business
Table 103. Rongsheng Latest Developments
LIST OFFIGURES
Figure 1. Picture of Monoclonal Antibody Diagnostic Reagents
Figure 2. Monoclonal Antibody Diagnostic Reagents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monoclonal Antibody Diagnostic Reagents Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Monoclonal Antibody Diagnostic Reagents Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Monoclonal Antibody Diagnostic Reagents Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country/Region (2024)
Figure 10. Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Enzyme Linked Immunosorbent Assays
Figure 12. Product Picture of Dot-immuogoldFiltration Assay
Figure 13. Product Picture of Double Antigen Sandwich Chemiluminescence Method
Figure 14. Product Picture of Recombinant Immunoblot Assay
Figure 15. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share byType in 2025
Figure 16. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share byType (2020-2025)
Figure 17. Monoclonal Antibody Diagnostic Reagents Consumed inTumor Monitoring
Figure 18. Global Monoclonal Antibody Diagnostic Reagents Market:Tumor Monitoring (2020-2025) & (K Dose)
Figure 19. Monoclonal Antibody Diagnostic Reagents Consumed in Virus Hepatitis Diagnosis
Figure 20. Global Monoclonal Antibody Diagnostic Reagents Market: Virus Hepatitis Diagnosis (2020-2025) & (K Dose)
Figure 21. Monoclonal Antibody Diagnostic Reagents Consumed in Venereal Disease Diagnosis
Figure 22. Global Monoclonal Antibody Diagnostic Reagents Market: Venereal Disease Diagnosis (2020-2025) & (K Dose)
Figure 23. Monoclonal Antibody Diagnostic Reagents Consumed in Others
Figure 24. Global Monoclonal Antibody Diagnostic Reagents Market: Others (2020-2025) & (K Dose)
Figure 25. Global Monoclonal Antibody Diagnostic Reagents Sale Market Share by Application (2024)
Figure 26. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Application in 2025
Figure 27. Monoclonal Antibody Diagnostic Reagents Sales by Company in 2025 (K Dose)
Figure 28. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Company in 2025
Figure 29. Monoclonal Antibody Diagnostic Reagents Revenue by Company in 2025 ($ millions)
Figure 30. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Company in 2025
Figure 31. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 34. Americas Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 35. APAC Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 36. APAC Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 37. Europe Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 38. Europe Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 40. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 41. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country in 2025
Figure 42. Americas Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country (2020-2025)
Figure 43. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 44. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 45. United States Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share by Region in 2025
Figure 50. APAC Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Region (2020-2025)
Figure 51. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 52. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 53. China Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 57. India Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country in 2025
Figure 61. Europe Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country (2020-2025)
Figure 62. Europe Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 63. Europe Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 64. Germany Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 65.France Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 72. Egypt Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Monoclonal Antibody Diagnostic Reagents in 2025
Figure 78. Manufacturing Process Analysis of Monoclonal Antibody Diagnostic Reagents
Figure 79. Industry Chain Structure of Monoclonal Antibody Diagnostic Reagents
Figure 80. Channels of Distribution
Figure 81. Global Monoclonal Antibody Diagnostic Reagents Sales MarketForecast by Region (2026-2031)
Figure 82. Global Monoclonal Antibody Diagnostic Reagents Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Monoclonal Antibody Diagnostic Reagents Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Monoclonal Antibody Diagnostic Reagents Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Monoclonal Antibody Diagnostic Reagents Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Monoclonal Antibody Diagnostic Reagents Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Monoclonal Antibody Diagnostic Reagents by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Monoclonal Antibody Diagnostic Reagents by Country/Region, 2020, 2024 & 2031
2.2 Monoclonal Antibody Diagnostic Reagents Segment by Type
2.2.1 Enzyme Linked Immunosorbent Assays
2.2.2 Dot-immuogold Filtration Assay
2.2.3 Double Antigen Sandwich Chemiluminescence Method
2.2.4 Recombinant Immunoblot Assay
2.3 Monoclonal Antibody Diagnostic Reagents Sales by Type
2.3.1 Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Type (2020-2025)
2.3.2 Global Monoclonal Antibody Diagnostic Reagents Revenue and Market Share by Type (2020-2025)
2.3.3 Global Monoclonal Antibody Diagnostic Reagents Sale Price by Type (2020-2025)
2.4 Monoclonal Antibody Diagnostic Reagents Segment by Application
2.4.1 Tumor Monitoring
2.4.2 Virus Hepatitis Diagnosis
2.4.3 Venereal Disease Diagnosis
2.4.4 Others
2.5 Monoclonal Antibody Diagnostic Reagents Sales by Application
2.5.1 Global Monoclonal Antibody Diagnostic Reagents Sale Market Share by Application (2020-2025)
2.5.2 Global Monoclonal Antibody Diagnostic Reagents Revenue and Market Share by Application (2020-2025)
2.5.3 Global Monoclonal Antibody Diagnostic Reagents Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Monoclonal Antibody Diagnostic Reagents Breakdown Data by Company
3.1.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales by Company (2020-2025)
3.1.2 Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Company (2020-2025)
3.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue by Company (2020-2025)
3.2.1 Global Monoclonal Antibody Diagnostic Reagents Revenue by Company (2020-2025)
3.2.2 Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Company (2020-2025)
3.3 Global Monoclonal Antibody Diagnostic Reagents Sale Price by Company
3.4 Key Manufacturers Monoclonal Antibody Diagnostic Reagents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Monoclonal Antibody Diagnostic Reagents Product Location Distribution
3.4.2 Players Monoclonal Antibody Diagnostic Reagents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MONOCLONAL ANTIBODY DIAGNOSTIC REAGENTS BY GEOGRAPHIC REGION
4.1 World Historic Monoclonal Antibody Diagnostic Reagents Market Size by Geographic Region (2020-2025)
4.1.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Monoclonal Antibody Diagnostic Reagents Market Size by Country/Region (2020-2025)
4.2.1 Global Monoclonal Antibody Diagnostic Reagents Annual Sales by Country/Region (2020-2025)
4.2.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue by Country/Region (2020-2025)
4.3 Americas Monoclonal Antibody Diagnostic Reagents Sales Growth
4.4 APAC Monoclonal Antibody Diagnostic Reagents Sales Growth
4.5 Europe Monoclonal Antibody Diagnostic Reagents Sales Growth
4.6 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Growth
5 AMERICAS
5.1 Americas Monoclonal Antibody Diagnostic Reagents Sales by Country
5.1.1 Americas Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025)
5.1.2 Americas Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025)
5.2 Americas Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
5.3 Americas Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody Diagnostic Reagents Sales by Region
6.1.1 APAC Monoclonal Antibody Diagnostic Reagents Sales by Region (2020-2025)
6.1.2 APAC Monoclonal Antibody Diagnostic Reagents Revenue by Region (2020-2025)
6.2 APAC Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
6.3 APAC Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Monoclonal Antibody Diagnostic Reagents by Country
7.1.1 Europe Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025)
7.1.2 Europe Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025)
7.2 Europe Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
7.3 Europe Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monoclonal Antibody Diagnostic Reagents by Country
8.1.1 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025)
8.1.2 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025)
8.2 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Type (2020-2025)
8.3 Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monoclonal Antibody Diagnostic Reagents
10.3 Manufacturing Process Analysis of Monoclonal Antibody Diagnostic Reagents
10.4 Industry Chain Structure of Monoclonal Antibody Diagnostic Reagents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Monoclonal Antibody Diagnostic Reagents Distributors
11.3 Monoclonal Antibody Diagnostic Reagents Customer
12 WORLD FORECAST REVIEW FOR MONOCLONAL ANTIBODY DIAGNOSTIC REAGENTS BY GEOGRAPHIC REGION
12.1 Global Monoclonal Antibody Diagnostic Reagents Market Size Forecast by Region
12.1.1 Global Monoclonal Antibody Diagnostic Reagents Forecast by Region (2026-2031)
12.1.2 Global Monoclonal Antibody Diagnostic Reagents Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Monoclonal Antibody Diagnostic Reagents Forecast by Type (2026-2031)
12.7 Global Monoclonal Antibody Diagnostic Reagents Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 KHB
13.1.1 KHB Company Information
13.1.2 KHB Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.1.3 KHB Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 KHB Main Business Overview
13.1.5 KHB Latest Developments
13.2 Leadman
13.2.1 Leadman Company Information
13.2.2 Leadman Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.2.3 Leadman Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Leadman Main Business Overview
13.2.5 Leadman Latest Developments
13.3 BioSino
13.3.1 BioSino Company Information
13.3.2 BioSino Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.3.3 BioSino Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BioSino Main Business Overview
13.3.5 BioSino Latest Developments
13.4 Chemclin
13.4.1 Chemclin Company Information
13.4.2 Chemclin Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.4.3 Chemclin Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Chemclin Main Business Overview
13.4.5 Chemclin Latest Developments
13.5 Wantai BioPharm
13.5.1 Wantai BioPharm Company Information
13.5.2 Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.5.3 Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Wantai BioPharm Main Business Overview
13.5.5 Wantai BioPharm Latest Developments
13.6 Rongsheng
13.6.1 Rongsheng Company Information
13.6.2 Rongsheng Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
13.6.3 Rongsheng Monoclonal Antibody Diagnostic Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Rongsheng Main Business Overview
13.6.5 Rongsheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Monoclonal Antibody Diagnostic Reagents Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Monoclonal Antibody Diagnostic Reagents Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Enzyme Linked Immunosorbent Assays
Table 4. Major Players of Dot-immuogoldFiltration Assay
Table 5. Major Players of Double Antigen Sandwich Chemiluminescence Method
Table 6. Major Players of Recombinant Immunoblot Assay
Table 7. Global Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 8. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Table 9. Global Monoclonal Antibody Diagnostic Reagents Revenue byType (2020-2025) & ($ million)
Table 10. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share byType (2020-2025)
Table 11. Global Monoclonal Antibody Diagnostic Reagents Sale Price byType (2020-2025) & (USD/Dose)
Table 12. Global Monoclonal Antibody Diagnostic Reagents Sale by Application (2020-2025) & (K Dose)
Table 13. Global Monoclonal Antibody Diagnostic Reagents Sale Market Share by Application (2020-2025)
Table 14. Global Monoclonal Antibody Diagnostic Reagents Revenue by Application (2020-2025) & ($ million)
Table 15. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Application (2020-2025)
Table 16. Global Monoclonal Antibody Diagnostic Reagents Sale Price by Application (2020-2025) & (USD/Dose)
Table 17. Global Monoclonal Antibody Diagnostic Reagents Sales by Company (2020-2025) & (K Dose)
Table 18. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Company (2020-2025)
Table 19. Global Monoclonal Antibody Diagnostic Reagents Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Company (2020-2025)
Table 21. Global Monoclonal Antibody Diagnostic Reagents Sale Price by Company (2020-2025) & (USD/Dose)
Table 22. Key Manufacturers Monoclonal Antibody Diagnostic Reagents Producing Area Distribution and Sales Area
Table 23. Players Monoclonal Antibody Diagnostic Reagents Products Offered
Table 24. Monoclonal Antibody Diagnostic Reagents Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Monoclonal Antibody Diagnostic Reagents Sales by Geographic Region (2020-2025) & (K Dose)
Table 28. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share Geographic Region (2020-2025)
Table 29. Global Monoclonal Antibody Diagnostic Reagents Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Monoclonal Antibody Diagnostic Reagents Sales by Country/Region (2020-2025) & (K Dose)
Table 32. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country/Region (2020-2025)
Table 33. Global Monoclonal Antibody Diagnostic Reagents Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025) & (K Dose)
Table 36. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country (2020-2025)
Table 37. Americas Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 39. Americas Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 40. APAC Monoclonal Antibody Diagnostic Reagents Sales by Region (2020-2025) & (K Dose)
Table 41. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share by Region (2020-2025)
Table 42. APAC Monoclonal Antibody Diagnostic Reagents Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 44. APAC Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 45. Europe Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025) & (K Dose)
Table 46. Europe Monoclonal Antibody Diagnostic Reagents Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 48. Europe Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 49. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Country (2020-2025) & (K Dose)
Table 50. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales byType (2020-2025) & (K Dose)
Table 52. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales by Application (2020-2025) & (K Dose)
Table 53. Key Market Drivers & Growth Opportunities of Monoclonal Antibody Diagnostic Reagents
Table 54. Key Market Challenges & Risks of Monoclonal Antibody Diagnostic Reagents
Table 55. Key IndustryTrends of Monoclonal Antibody Diagnostic Reagents
Table 56. Monoclonal Antibody Diagnostic Reagents Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Monoclonal Antibody Diagnostic Reagents Distributors List
Table 59. Monoclonal Antibody Diagnostic Reagents Customer List
Table 60. Global Monoclonal Antibody Diagnostic Reagents SalesForecast by Region (2026-2031) & (K Dose)
Table 61. Global Monoclonal Antibody Diagnostic Reagents RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Monoclonal Antibody Diagnostic Reagents SalesForecast by Country (2026-2031) & (K Dose)
Table 63. Americas Monoclonal Antibody Diagnostic Reagents Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Monoclonal Antibody Diagnostic Reagents SalesForecast by Region (2026-2031) & (K Dose)
Table 65. APAC Monoclonal Antibody Diagnostic Reagents Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Monoclonal Antibody Diagnostic Reagents SalesForecast by Country (2026-2031) & (K Dose)
Table 67. Europe Monoclonal Antibody Diagnostic Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Monoclonal Antibody Diagnostic Reagents SalesForecast by Country (2026-2031) & (K Dose)
Table 69. Middle East & Africa Monoclonal Antibody Diagnostic Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Monoclonal Antibody Diagnostic Reagents SalesForecast byType (2026-2031) & (K Dose)
Table 71. Global Monoclonal Antibody Diagnostic Reagents RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Monoclonal Antibody Diagnostic Reagents SalesForecast by Application (2026-2031) & (K Dose)
Table 73. Global Monoclonal Antibody Diagnostic Reagents RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. KHB Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 75. KHB Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 76. KHB Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 77. KHB Main Business
Table 78. KHB Latest Developments
Table 79. Leadman Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 80. Leadman Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 81. Leadman Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 82. Leadman Main Business
Table 83. Leadman Latest Developments
Table 84. BioSino Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 85. BioSino Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 86. BioSino Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 87. BioSino Main Business
Table 88. BioSino Latest Developments
Table 89. Chemclin Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 90. Chemclin Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 91. Chemclin Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 92. Chemclin Main Business
Table 93. Chemclin Latest Developments
Table 94. Wantai BioPharm Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 95. Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 96. Wantai BioPharm Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 97. Wantai BioPharm Main Business
Table 98. Wantai BioPharm Latest Developments
Table 99. Rongsheng Basic Information, Monoclonal Antibody Diagnostic Reagents Manufacturing Base, Sales Area and Its Competitors
Table 100. Rongsheng Monoclonal Antibody Diagnostic Reagents Product Portfolios and Specifications
Table 101. Rongsheng Monoclonal Antibody Diagnostic Reagents Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 102. Rongsheng Main Business
Table 103. Rongsheng Latest Developments
LIST OFFIGURES
Figure 1. Picture of Monoclonal Antibody Diagnostic Reagents
Figure 2. Monoclonal Antibody Diagnostic Reagents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monoclonal Antibody Diagnostic Reagents Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Monoclonal Antibody Diagnostic Reagents Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Monoclonal Antibody Diagnostic Reagents Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country/Region (2024)
Figure 10. Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Enzyme Linked Immunosorbent Assays
Figure 12. Product Picture of Dot-immuogoldFiltration Assay
Figure 13. Product Picture of Double Antigen Sandwich Chemiluminescence Method
Figure 14. Product Picture of Recombinant Immunoblot Assay
Figure 15. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share byType in 2025
Figure 16. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share byType (2020-2025)
Figure 17. Monoclonal Antibody Diagnostic Reagents Consumed inTumor Monitoring
Figure 18. Global Monoclonal Antibody Diagnostic Reagents Market:Tumor Monitoring (2020-2025) & (K Dose)
Figure 19. Monoclonal Antibody Diagnostic Reagents Consumed in Virus Hepatitis Diagnosis
Figure 20. Global Monoclonal Antibody Diagnostic Reagents Market: Virus Hepatitis Diagnosis (2020-2025) & (K Dose)
Figure 21. Monoclonal Antibody Diagnostic Reagents Consumed in Venereal Disease Diagnosis
Figure 22. Global Monoclonal Antibody Diagnostic Reagents Market: Venereal Disease Diagnosis (2020-2025) & (K Dose)
Figure 23. Monoclonal Antibody Diagnostic Reagents Consumed in Others
Figure 24. Global Monoclonal Antibody Diagnostic Reagents Market: Others (2020-2025) & (K Dose)
Figure 25. Global Monoclonal Antibody Diagnostic Reagents Sale Market Share by Application (2024)
Figure 26. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Application in 2025
Figure 27. Monoclonal Antibody Diagnostic Reagents Sales by Company in 2025 (K Dose)
Figure 28. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Company in 2025
Figure 29. Monoclonal Antibody Diagnostic Reagents Revenue by Company in 2025 ($ millions)
Figure 30. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Company in 2025
Figure 31. Global Monoclonal Antibody Diagnostic Reagents Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 34. Americas Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 35. APAC Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 36. APAC Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 37. Europe Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 38. Europe Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales 2020-2025 (K Dose)
Figure 40. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Revenue 2020-2025 ($ millions)
Figure 41. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country in 2025
Figure 42. Americas Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country (2020-2025)
Figure 43. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 44. Americas Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 45. United States Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share by Region in 2025
Figure 50. APAC Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Region (2020-2025)
Figure 51. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 52. APAC Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 53. China Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 57. India Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country in 2025
Figure 61. Europe Monoclonal Antibody Diagnostic Reagents Revenue Market Share by Country (2020-2025)
Figure 62. Europe Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 63. Europe Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 64. Germany Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 65.France Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Monoclonal Antibody Diagnostic Reagents Sales Market Share by Application (2020-2025)
Figure 72. Egypt Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Monoclonal Antibody Diagnostic Reagents Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Monoclonal Antibody Diagnostic Reagents in 2025
Figure 78. Manufacturing Process Analysis of Monoclonal Antibody Diagnostic Reagents
Figure 79. Industry Chain Structure of Monoclonal Antibody Diagnostic Reagents
Figure 80. Channels of Distribution
Figure 81. Global Monoclonal Antibody Diagnostic Reagents Sales MarketForecast by Region (2026-2031)
Figure 82. Global Monoclonal Antibody Diagnostic Reagents Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Monoclonal Antibody Diagnostic Reagents Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Monoclonal Antibody Diagnostic Reagents Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Monoclonal Antibody Diagnostic Reagents Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Monoclonal Antibody Diagnostic Reagents Revenue Market ShareForecast by Application (2026-2031)
